Santhera considering strategic options following decisions regarding Catena and Raxone March 4, 2013 No Comments
Canadian authorities assessing reimbursement for newly approved cystic fibrosis treatment Kalydeco Dec. 4, 2012 No Comments
Health Canada approves Cymbalta for pain associated with osteoarthritis of the knee Nov. 13, 2012 No Comments
RSS